Kuan-Hung (Peter) Yeh

Kuan-Hung (Peter) Yeh

A PhD student at UCSD Biomedical Informatics

Publications

† co-first author    * corresponding author

Peer-Reviewed Journal Articles

  1. Yeh, K. H., Ahuja, D., Patel, S. B., Xu, R., Park, S., …, Singh, S.* (2026). “Adjunctive GLP-1 Receptor Agonists in Patients with Inflammatory Bowel Diseases and Obesity and/or Diabetes: A Target Trial Emulation.” Clinical Gastroenterology and Hepatology.
  2. Ahuja, D., Park, S. K., Yeh, K. H.†, Patel, S. B., Goodwin, S. W., …, Singh, S.* (2026). “Overall and Comparative Risk of Shingles with Advanced Therapies in Patients with Inflammatory Bowel Diseases.” Alimentary Pharmacology & Therapeutics, 63(5), 686–695.
  3. Park, S., Ahuja, D., Yeh, K. H.†, Patel, S. B., Goodwin, S. W., …, Singh, S.* (2026). “Comparative Safety of Advanced Therapies for Crohn Disease.” JAMA Network Open, 9(2), e2557922.
  4. Ahuja, D., Yeh, K. H.†, Patel, S. B., Park, S. K., Xu, R., & Singh, S.* (2025). “Risk of Tuberculosis with Advanced Therapies in 20,705 Patients with Inflammatory Bowel Diseases in Low Incidence Regions—A US Claims-Based Study.” Alimentary Pharmacology & Therapeutics.
  5. Ahuja, D., Dziegielewski, C., Yeh, K. H.†, Patel, S. B., Goodwin, S. W., …, Singh, S.* (2025). “Comparative Safety of Advanced Therapies in Patients with Ulcerative Colitis: An Administrative Claims-Based Study.” American Journal of Gastroenterology.
  6. Corroon, J., Bradley, R., Grant, I., Bancks, M. P., … Yeh, K. H., et al. (2025). “Lifetime Cannabis Use and Incident Hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.” Hypertension, 82(10), 1641–1652.
  7. Solitano, V., Ahuja, D., Lee, H. H., Gaikwad, R., Yeh, K. H., …, Singh, S.* (2025). “Comparative Safety of JAK Inhibitors vs TNF Antagonists in Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis.” JAMA Network Open, 8(9), e2531204.
  8. Ahuja, D., Yeh, K. H.†, Patel, S. B., Lee, H. H., Goodwin, S. W., …, Singh, S.* (2025). “Comparative Safety of Janus Kinase Inhibitors vs. Tumor Necrosis Factor Antagonists in Patients with Inflammatory Bowel Diseases.” Clinical Gastroenterology and Hepatology.
  9. McCurdy, J. D.*, Munir, J., Parlow, S., Sambhi, G., … Yeh, K. H., et al. (2025). “The Impact of Setons on Perianal Fistula Outcomes in Patients with Crohn’s Disease Treated with Anti-TNF Therapy: A Multicentre Study.” Alimentary Pharmacology & Therapeutics, 61(10), 1671–1679.
  10. Haynesworth, A., Yeh, K. H.†, Lee, H. H., Kirkpatrick, M., …, Singh, S.* (2025). “Long-Term Outcomes of an Infliximab-First Versus Vedolizumab-First Treatment Strategy in Biologic-Naïve Patients with Ulcerative Colitis.” Alimentary Pharmacology & Therapeutics, 61(4), 693–701.
  11. Chan, H. C., Huang, C. C., Huang, C. C., Chattopadhyay, A., Yeh, K. H., …, Lu, T. P.* (2022). “Predicting Colon Cancer-Specific Survival for the Asian Population Using National Cancer Registry Data from Taiwan.” Annals of Surgical Oncology, 29(2), 853–863. doi: 10.1245/s10434-021-10646-2

Manuscripts Under Review & In Preparation

  1. Hupé, M., … Yeh, K. H., et al. (2026). “Risk of Perianal Penetrating Complications Among Patients with Non-Penetrating Crohn’s Disease Initiating Advanced Therapies: A Retrospective Cohort Study.” Journal of Crohn’s and Colitis (under revision).
  2. Silverman, A.*, … Yeh, K. H., et al. (2026). “Combining Immunomodulators with Biologic Therapies vs. Biologic Monotherapy in Patients with Inflammatory Bowel Diseases: Target Trial Emulations.” Therapeutic Advances in Gastroenterology (under revision).
  3. Ahuja, D., … Yeh, K. H., …, Singh, S.* (2026). “Upadacitinib Is Associated with the Lowest Risk of Treatment Failure Among Advanced Therapies for Ulcerative Colitis.” Clinical Gastroenterology and Hepatology (under revision).
  4. Ahuja, D., Yeh, K. H., Park, S. K., Qi, Y., Patel, S., …, Singh, S.* (2026). “Cancer Risk with Advanced Therapies in Patients with Inflammatory Bowel Diseases: An Administrative Claims-Based Study.” Clinical Gastroenterology and Hepatology (under revision).
  5. Neel, N., … Yeh, K. H., et al. (2026). “Physician Evaluation of a Multi-Agent LLM Framework for ICU Readmission Risk Stratification and Discharge Planning.” Submitted (under review).
  6. Yeh, K. H., Singh, S., & Xu, R.* (2026). “Trial Data Fusion: Indirect Comparisons Beyond Covariate Shift.” Manuscript in preparation.

Peer-Reviewed Conference Proceedings

  1. Yeh, K. H., Lin, C. H., Hsiao, T. H., & Lu, T. P.* (2020). “Genome-Wide Association Study (GWAS) on Metabolic Syndrome in Subjects with Abdominal Obesity in a Taiwanese Population.” 2020 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), Seoul, Korea, pp. 1403–1407. doi: 10.1109/BIBM49941.2020.9313373

Conference Abstracts & Presentations

  1. Yeh, K. H., Xu, R., & Singh, S.* (2026). “Trial Data Fusion: Indirect Comparisons Beyond Covariate Shift.” American Causal Inference Conference (ACIC) 2026, Poster Presentation. (Presenting Author)
  2. Ahuja, D., Yeh, K. H., Park, S. K., Qi, Y., Patel, S., …, Singh, S.* (2026). “Tu1584: Cancer Risk with Advanced Therapies in Patients with Inflammatory Bowel Diseases: An Administrative Claims-Based Study.” Digestive Disease Week (DDW) 2026. Gastroenterology, 170(6), S-1314.
  3. Hupé, M., Ahuja, D., Yeh, K. H., Patel, S., Xu, R., …, Singh, S.* (2026). “Mo1554: Comparative Effectiveness of Advanced Therapies for Preventing Penetrating Complications in Crohn’s Disease: An Administrative Claims-Based Study.” Digestive Disease Week (DDW) 2026. Gastrointestinal Endoscopy, 103(5), S-1185.
  4. Ahuja, D., Park, S. K., Yeh, K. H., Patel, S., Goodwin, S., …, Singh, S.* (2025). “S1872: Overall and Comparative Risk of Shingles with Advanced Therapies in Patients with Inflammatory Bowel Diseases.” ACG Annual Scientific Meeting 2025. American Journal of Gastroenterology, 120(10S2).
  5. Lee, H. H., Ahuja, D., Solitano, V., Gaikwad, R., Yeh, K. H., …, Singh, S.* (2025). “Tu1850: Comparative Risk of Major Adverse Cardiovascular Events with JAK Inhibitors vs. TNF Antagonists in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review and Meta-Analysis.” Digestive Disease Week (DDW) 2025. Gastroenterology, 169(1), S-1522.
  6. Gaikwad, R., Ahuja, D., Solitano, V., Lee, H. H., Yeh, K. H., …, Jairath, V.* (2025). “Tu1849: Comparative Risk of Venous Thromboembolism with JAK Inhibitors vs. TNF Antagonists in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review and Meta-Analysis.” Digestive Disease Week (DDW) 2025. Gastroenterology, 169(1), S-1522.
  7. McCurdy, J. D.*, Munir, J., Parlow, S., Sambhi, G., … Yeh, K. H., et al. (2025). “124: The Impact of Setons on Perianal Fistula Outcomes in Patients with Crohn’s Disease Treated with Anti-TNF Therapy: A Multicenter Study.” Digestive Disease Week (DDW) 2025. Gastroenterology, 169(1), S-35–S-36.
  8. Pandita, P., Lee, H. H., Yeh, K. H., Haynesworth, A., …, Singh, S.* (2025). “Tu1856: Treatment Sequencing: Long-Term Outcomes of an Infliximab-First vs. Ustekinumab-First Treatment Strategy in Biologic-Naive Patients with Crohn’s Disease.” Digestive Disease Week (DDW) 2025. Gastroenterology, 169(1), S-1525.
  9. Yeh, K. H., Lu, T. P. (2019). “Using National Cancer Registry Data to Develop a Prediction Model for Colon Cancer in Taiwan.” 2019 Taiwan Public Health Joint Annual Conference, Taipei, Taiwan. Poster Presentation.

Last updated: July 2026